ConductScience.org, home

Paper10949

Pharmacological effects of labetalol in man.

Richards DA. Br J Clin Pharmacol, 1976. Cited by 108 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacological effects of labetalol in man. Papers, record 10949. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10949

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacological effects of labetalol in man.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
108
iCite
Relative citation ratio, by iCite
6.71
iCite
Revised in PubMed
2013-11-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Richards DAD A

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EthanolaminesMajor topic
LabetalolMajor topic
Adrenergic alpha-Antagonists
Adrenergic beta-Antagonists
Blood Pressure
Dose-Response Relationship, Drug
Heart Rate
Humans
Male
Respiration

Source PubMed

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.

PMIDTitleJournalYearIn PapersSource
29,925,529Octopamine signaling in the metazoan pathogen Schistosoma mansoni: localization, small-molecule screening and opportunities for drug development.Dis Model Mech2018https://conductscience.org/library/papers/29925529PubMed
24,863,753Current and newer agents for hypertensive emergencies.Curr Hypertens Rep2014https://conductscience.org/library/papers/24863753PubMed
8,527,263The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.Br J Clin Pharmacol1995https://conductscience.org/library/papers/8527263PubMed
6,370,541Clinical pharmacokinetics of labetalol.Clin Pharmacokinet1984https://conductscience.org/library/papers/6370541PubMed
6,151,889Pharmacology of combined alpha-beta-blockade. I.Drugs1984https://conductscience.org/library/papers/6151889PubMed
3,889,356Propranolol versus labetalol: interesting differences in efficacy.J Natl Med Assoc1985https://conductscience.org/library/papers/3889356PubMed
3,881,105Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo.Br Heart J1985https://conductscience.org/library/papers/3881105PubMed
3,154,918Labetalol in normotensive patients with angina pectoris.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154918PubMed
2,908,732Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/2908732PubMed
2,663,413Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.Drugs1989https://conductscience.org/library/papers/2663413PubMed
2,616,255Half-life of maternal labetalol in a premature infant.Pharm Weekbl Sci1989https://conductscience.org/library/papers/2616255PubMed
861,131Effects of labetalol and propranolol on histamine-induced bronchoconstriction in normal subjects.Br J Clin Pharmacol1977https://conductscience.org/library/papers/861131PubMed
760,749Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.Br J Clin Pharmacol1979https://conductscience.org/library/papers/760749PubMed
526,406Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526406PubMed
526,402Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526402PubMed
526,398Long-term treatment of hypertension with labetalol.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526398PubMed
526,393Labetalol in the treatment of patients with hypertension and renal function impairment.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526393PubMed
526,391Effect of labetalol on continuous ambulatory blood pressure.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526391PubMed
520,398Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/520398PubMed
520,397Effects of labetalol and propranolol on blood pressure at rest and during isometric and dynamic exercise.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/520397PubMed

See all 27 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10949

GET https://conductscience.org/api/papers/v1/10949/cited_by?page=2